Marshall Wace, LLP Pfizer Inc Put Options Transaction History

Marshall Wace, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $77.7 Million - $89.2 Million	3,000,000 New	3,000,000 $83.3 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $751,296 - $869,232	20,800 Added 23.14%	110,700 $4.06 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $8.78 Million - $11.4 Million	-222,800 Reduced 71.25%	89,900 $3.67 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $100,200 - $130,800	2,400 Added 0.77%	312,700 $16 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $2.74 Million - $3.35 Million	62,700 Added 25.32%	310,300 $13.6 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $9.97 Million - $11.8 Million	214,200 Added 641.32%	247,600 $13 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $20.5 Million - $25.4 Million	-447,500 Reduced 93.05%	33,400 $1.73 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $15.7 Million - $23.3 Million	380,100 Added 377.08%	480,900 $28.4 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $3.96 Million - $5.08 Million	100,800 New	100,800 $4.34 Million

3,256

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $140B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.